Table 2.

Healing rates of duodenal ulcers

	Keverprazan	Lansoprazole
Week 6
Full analysis set	n = 180	n = 178
No. (%) of healed patients	170 (94.4)	166 (93.3)
Difference from LPZ with 95% CI	1.19 (−4.0, 6.5)
P Value	0.6404
Per protocol set	n = 166	n = 167
No. (%) of healed patients	163 (98.2)	163 (97.6)
Difference from LPZ with 95% CI	0.6 (−3.1, 4.4)
P Value	1.0000
Week 4
Full analysis set	n = 180	n = 178
No. (%) of healed patients	151 (83.9)	143 (80.3)
Difference from LPZ with 95% CI	3.6 (−4.5, 11.6)
P Value	0.3805
Per protocol set	n = 166	n = 167
No. (%) of healed patients	144 (86.8)	143 (85.6)
Difference from LPZ with 95% CI	1.1 (−6.4, 8.7)
P Value	0.7675

Noninferiority was assessed using the Miettinen-Nurminen method with a noninferiority margin of −8%.

LPZ, lansoprazole.